Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat

Mizuki Ninomiya, Mitsuo Shimada, Noboru Harada, Satoko Shiotani, Shoji Hiroshige, Yuji Soejima, Taketoshi Suehiro, Keizo Sugimachi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Despite growing evidence that reactive oxygen species are responsible for deleterious effects of ischemia-reperfusion (I/R) injury of the liver, there exists, until now, no reliable antioxidant therapeutics applicable in the clinical setting. We investigated the effects of free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), using an isolated liver perfusion model to elucidate its possible therapeutic effects on hepatic warm I/R injury. Isolated livers from Wistar rats were reperfused for 120 min with an oxygenated KrebsHenseleit bicarbonate buffer after 1 hr of warm ischemia. Addition of MCI-186 (1 mg/L) into the perfusate significantly improved portal flow, hepatic enzyme release into the perfusate, total bile production, histologic alteration, and malondialdehyde concentration but not sinusoidal endothelial cell function as assessed by the clearance of hyaluronic acid. MCI-186 seems to have protective effects against hepatic warm I/R injury by attenuating the damage of the hepatocyte, which is the major target of oxidative damage in this model.

Original languageEnglish
Pages (from-to)1470-1472
Number of pages3
JournalTransplantation
Volume74
Issue number10
DOIs
Publication statusPublished - Nov 1 2002

Fingerprint

Warm Ischemia
Reperfusion
Liver
Reperfusion Injury
Free Radical Scavengers
Therapeutic Uses
Hyaluronic Acid
Bicarbonates
Malondialdehyde
Bile
phenylmethylpyrazolone
Wistar Rats
Hepatocytes
Reactive Oxygen Species
Buffers
Endothelial Cells
Perfusion
Antioxidants
Enzymes

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. / Ninomiya, Mizuki; Shimada, Mitsuo; Harada, Noboru; Shiotani, Satoko; Hiroshige, Shoji; Soejima, Yuji; Suehiro, Taketoshi; Sugimachi, Keizo.

In: Transplantation, Vol. 74, No. 10, 01.11.2002, p. 1470-1472.

Research output: Contribution to journalArticle

Ninomiya, M, Shimada, M, Harada, N, Shiotani, S, Hiroshige, S, Soejima, Y, Suehiro, T & Sugimachi, K 2002, 'Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat', Transplantation, vol. 74, no. 10, pp. 1470-1472. https://doi.org/10.1097/00007890-200211270-00021
Ninomiya, Mizuki ; Shimada, Mitsuo ; Harada, Noboru ; Shiotani, Satoko ; Hiroshige, Shoji ; Soejima, Yuji ; Suehiro, Taketoshi ; Sugimachi, Keizo. / Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat. In: Transplantation. 2002 ; Vol. 74, No. 10. pp. 1470-1472.
@article{bb6bb7a11fe743d982bad60b3ca81f79,
title = "Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat",
abstract = "Despite growing evidence that reactive oxygen species are responsible for deleterious effects of ischemia-reperfusion (I/R) injury of the liver, there exists, until now, no reliable antioxidant therapeutics applicable in the clinical setting. We investigated the effects of free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), using an isolated liver perfusion model to elucidate its possible therapeutic effects on hepatic warm I/R injury. Isolated livers from Wistar rats were reperfused for 120 min with an oxygenated KrebsHenseleit bicarbonate buffer after 1 hr of warm ischemia. Addition of MCI-186 (1 mg/L) into the perfusate significantly improved portal flow, hepatic enzyme release into the perfusate, total bile production, histologic alteration, and malondialdehyde concentration but not sinusoidal endothelial cell function as assessed by the clearance of hyaluronic acid. MCI-186 seems to have protective effects against hepatic warm I/R injury by attenuating the damage of the hepatocyte, which is the major target of oxidative damage in this model.",
author = "Mizuki Ninomiya and Mitsuo Shimada and Noboru Harada and Satoko Shiotani and Shoji Hiroshige and Yuji Soejima and Taketoshi Suehiro and Keizo Sugimachi",
year = "2002",
month = "11",
day = "1",
doi = "10.1097/00007890-200211270-00021",
language = "English",
volume = "74",
pages = "1470--1472",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Beneficial effect of MCI-186 on hepatic warm ischemia-reperfusion in the rat

AU - Ninomiya, Mizuki

AU - Shimada, Mitsuo

AU - Harada, Noboru

AU - Shiotani, Satoko

AU - Hiroshige, Shoji

AU - Soejima, Yuji

AU - Suehiro, Taketoshi

AU - Sugimachi, Keizo

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Despite growing evidence that reactive oxygen species are responsible for deleterious effects of ischemia-reperfusion (I/R) injury of the liver, there exists, until now, no reliable antioxidant therapeutics applicable in the clinical setting. We investigated the effects of free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), using an isolated liver perfusion model to elucidate its possible therapeutic effects on hepatic warm I/R injury. Isolated livers from Wistar rats were reperfused for 120 min with an oxygenated KrebsHenseleit bicarbonate buffer after 1 hr of warm ischemia. Addition of MCI-186 (1 mg/L) into the perfusate significantly improved portal flow, hepatic enzyme release into the perfusate, total bile production, histologic alteration, and malondialdehyde concentration but not sinusoidal endothelial cell function as assessed by the clearance of hyaluronic acid. MCI-186 seems to have protective effects against hepatic warm I/R injury by attenuating the damage of the hepatocyte, which is the major target of oxidative damage in this model.

AB - Despite growing evidence that reactive oxygen species are responsible for deleterious effects of ischemia-reperfusion (I/R) injury of the liver, there exists, until now, no reliable antioxidant therapeutics applicable in the clinical setting. We investigated the effects of free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), using an isolated liver perfusion model to elucidate its possible therapeutic effects on hepatic warm I/R injury. Isolated livers from Wistar rats were reperfused for 120 min with an oxygenated KrebsHenseleit bicarbonate buffer after 1 hr of warm ischemia. Addition of MCI-186 (1 mg/L) into the perfusate significantly improved portal flow, hepatic enzyme release into the perfusate, total bile production, histologic alteration, and malondialdehyde concentration but not sinusoidal endothelial cell function as assessed by the clearance of hyaluronic acid. MCI-186 seems to have protective effects against hepatic warm I/R injury by attenuating the damage of the hepatocyte, which is the major target of oxidative damage in this model.

UR - http://www.scopus.com/inward/record.url?scp=0036853007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036853007&partnerID=8YFLogxK

U2 - 10.1097/00007890-200211270-00021

DO - 10.1097/00007890-200211270-00021

M3 - Article

C2 - 12451250

AN - SCOPUS:0036853007

VL - 74

SP - 1470

EP - 1472

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 10

ER -